NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that the University of Pittsburgh will use its SmartChip Real-Time PCR System in genomics, gene expression, and disease studies that are funded by the National Institutes of Health.

The Pittsburgh researchers are using $350,000 of a $3.5 million American Recovery and Reinvestment Act grant to support their efforts. The award is partially funding two research programs conducted under a collaboration with Pittsburgh, Harvard University, Boston University, National Jewish Hospital, and Wake Forest University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.